3-Hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid 3,4-dioxygenase inhibitor NCR-631 (Q73302839)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

3-Hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid 3,4-dioxygenase inhibitor NCR-631 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Fornstedt-Wallin B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Lundström J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Fredriksson G

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Schwarcz R

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Luthman J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

15-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

Presence of 3-hydroxyanthranilic acid in rat tissues and evidence for its production from anthranilic acid in the brain

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

3-Hydroxyanthranilic acid metabolism. IV. Spectrophotometric evidence for the formation of an intermediate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Quinolinic acid accumulation and functional deficits following experimental spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Delayed increases in regional brain quinolinic acid follow transient ischemia in the gerbil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

4-chloro-3-hydroxyanthranilate inhibits brain 3-hydroxyanthranate oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Effects of the 3-hydroxyanthranilic acid analogue NCR-631 on anoxia-, IL-1 beta- and LPS-induced hippocampal pyramidal cell loss in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Seasonal variations in the stability of monoamines and their metabolites in perchloric acid as measured by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Metabolism of l‐Tryptophan to Kynurenate and Quinolinate in the Central Nervous System: Effects of 6‐Chlorotryptophan and 4‐Chloro‐3‐Hydroxyanthranilate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Rat 3-hydroxyanthranilic acid oxygenase: purification from the liver and immunocytochemical localization in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Metabolism of 6-chlorotryptophan to 4-chloro-3-hydroxyanthranilic acid: a potent inhibitor of 3-hydroxyanthranilic acid oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Effect of dietary protein level on some key enzymes of the tryptophan-NAD pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Preparation of 4-halo-3-hydroxyanthranilates and demonstration of their inhibition of 3-hydroxyanthranilate oxygenase activity in rat and human brain tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Identification and quantification of kynurenic acid in human brain tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

4-Halo-3-hydroxyanthranilic acids: Potent competitive inhibitors of 3-hydroxy-anthranilic acid oxygenase in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

4-Chloro-3-hydroxyanthranilate inhibits quinolinate production in the rat hippocampus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

Quinolinic acid in neurological disease: opportunities for novel drug discovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900683-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00683-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10611459%20AND%20SRC:MED&resulttype=core&format=json